美国 · SEC FORM 4
HWH International Inc.
HWH · Nasdaq · CIK 0001897245 · Healthcare
内部人信号
1 位买方 · 1 条买入交易行 · $500.0K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 46.0
- 45.9
- 45.8
- 45.7
- 45.6
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- —
- 3M
- —
- 6M
- —
- 12M
- —
波动率与流动性
- 波动率
- —
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -303.4%
- ROE
- -100.4%
- 细分行业
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-08 | Alset Inc.; Chan Heng Fai Ambrose | 买入 (P) | Common Stock | 250,000 | USD 2.00 | USD 500,000 | SEC 申报 ↗ |
| 2024-12-24 | Alset Inc.; Chan Heng Fai Ambrose | 买入 (P) | Common Stock | 1,300,000 | USD 0.45 | USD 585,000 | SEC 申报 ↗ |
| 2024-11-25 | Alset Inc.; Chan Heng Fai Ambrose | 买入 (P) | Common Stock | 4,411,764 | USD 0.68 | USD 3,000,000 | SEC 申报 ↗ |
| 2024-09-24 | Alset Inc.; Alset International Ltd; Chan Heng Fai Ambrose | 买入 (P) | Common Stock | 6,034,537 | USD 0.63 | USD 3,801,758 | SEC 申报 ↗ |
| 2024-01-10 | WOLVERINE ASSET MANAGEMENT LLC | 买入 (P) | Class A Common Stock | 200,165 | USD 10.66 | USD 2,133,759 | SEC 申报 ↗ |
| 2023-08-04 | Chan Heng Fai Ambrose | 买入 (P) | Class A Common Stock | 410 | USD 7.39 | USD 3,030 | SEC 申报 ↗ |
| 2023-08-03 | Chan Heng Fai Ambrose | 买入 (P) | Class A Common Stock | 31,871 | USD 7.68 | USD 244,694 | SEC 申报 ↗ |
| 2023-08-02 | Chan Heng Fai Ambrose | 买入 (P) | Class A Common Stock | 32,519 | USD 6.53 | USD 212,381 | SEC 申报 ↗ |
Form 4 申报证据
9 transaction lines in the latest 365-day window; 36 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | Wu William Wai Leung | 奖励／授予 (A) | Common Stock | 40,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-07 | Wong Tat Keung | 奖励／授予 (A) | Common Stock | 20,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-07 | Wong Shui Yeung | 奖励／授予 (A) | Common Stock | 20,000 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (9 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | Wu William Wai Leung | 奖励／授予 (A) | Common Stock | 40,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-07 | Wong Tat Keung | 奖励／授予 (A) | Common Stock | 20,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-07 | Wong Shui Yeung | 奖励／授予 (A) | Common Stock | 20,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-07 | Wei Rongguo | 奖励／授予 (A) | Common Stock | 50,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-07 | Lim Sheng Hon Danny | 奖励／授予 (A) | Common Stock | 135,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-07 | Chan Heng Fai Ambrose | 奖励／授予 (A) | Common Stock | 1,480,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-05 | Alset Inc.; Alset International Ltd; Chan Heng Fai Ambrose | J (J) | Common Stock | 320,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-08 | Alset Inc.; Chan Heng Fai Ambrose | 买入 (P) | Common Stock | 250,000 | USD 2.00 | USD 500,000 | SEC 申报 ↗ |
| 2025-11-26 | Chan Heng Fai Ambrose | 奖励／授予 (A) | Common Stock | 1,000,000 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | HWH |
| CIK | 0001897245 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 36 transaction lines from 2023-05-01 to 2026-08-07 14 P purchase lines · 6 S sale lines · 16 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.